Valuation: Abbott Laboratories

Market Cap 178B 160B 149B 135B 254B 16,956B 256B 1,794B 701B 8,800B 669B 654B 28,304B P/E 2026 *
30.4x
P/E 2027 * 23.5x
Enterprise Value 202B 182B 170B 154B 289B 19,234B 290B 2,035B 795B 9,983B 759B 742B 32,107B EV / Sales 2026 *
4.03x
EV / Sales 2027 * 3.65x
Free-Float
86.16%
Yield 2026 *
2.5%
Yield 2027 * 2.66%
1 day+0.35%
1 week+4.29%
Current month+4.19%
1 month-0.12%
3 months+15.75%
6 months+1.90%
Current year-17.81%
1 week 98.2
Extreme 98.2
104.06
1 month 95.06
Extreme 95.06
104.54
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
132.02
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
30/09/26 Free

Director

333 0.0000%
30/09/26 Free

Director

318 0.0000%
30/09/26 Free

Director

381 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.35%+4.29%-22.74%+13.32% 178B
+1.31%+10.20%-2.39%+30.95% 119B
-0.33%+2.26%-23.89%+9.21% 108B
+1.23%+0.99%-45.59%-9.75% 75.27B
+1.84%+5.96%+5.74%+77.89% 62.99B
-1.61%-0.16%+16.29%+64.27% 53.46B
+0.81%+4.85%+0.28%-26.98% 51.04B
+1.67%+4.41%-16.94%+24.13% 40.99B
-1.87%-0.98%+26.07%+9.56% 32.1B
+0.64%+1.35% - - 31.32B
Average +0.40%+3.18%-7.02%+21.40% 75.21B
Weighted average by Cap. +0.50%+4.00%-12.42%+20.22%

Financials

2026 *2027 *
Net sales 50.2B 45.13B 42.12B 38.17B 71.67B 4,777B 72.11B 505B 197B 2,479B 188B 184B 7,974B 54.53B 49.02B 45.75B 41.46B 77.85B 5,189B 78.33B 549B 214B 2,693B 205B 200B 8,662B
Net income 6.16B 5.54B 5.17B 4.69B 8.8B 586B 8.85B 62.06B 24.23B 304B 23.14B 22.64B 979B 7.84B 7.05B 6.58B 5.96B 11.2B 746B 11.27B 78.97B 30.84B 387B 29.45B 28.81B 1,246B
Net Debt 23.94B 21.52B 20.09B 18.2B 34.18B 2,278B 34.39B 241B 94.12B 1,182B 89.88B 87.93B 3,803B 20.96B 18.84B 17.58B 15.94B 29.92B 1,994B 30.11B 211B 82.4B 1,035B 78.68B 76.98B 3,329B
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
14/10/26 $102.97 +0.35% 7,275,971
13/10/26 $102.61 +0.78% 9,864,564
12/10/26 $101.82 +2.23% 7,147,039
09/10/26 $99.60 +1.13% 6,962,016
08/10/26 $98.49 -0.24% 13,909,636
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
102.97USD
Average target price
120.72USD
Spread / Average Target
+17.23%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott Laboratories